Nearsightedness in Children--A Study to Determine if Daily Eye Drops Can Slow the Progression

Official Title: CHILDHOOD ATROPINE FOR MYOPIA PROGRESSION (CHAMP): A 3-ARM RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED, PHASE 3 STUDY OF ATROPINE SULFATE OPHTHALMIC SOLUTION 0.01% AND 0.02%

Purpose:

The purpose of the study is to determine if a daily eye drop will help slow the progression of nearsightedness in children.

Eligibility criteria:

Your child may be eligible for this study if he/she is:
*Ages 3- 17
*Nearsighted

Participants will complete visits for follow-up (every 6 months) and to pick up study eye drops (every 3 months).

Please have your child’s current eye glasses prescription available when you call.

Contact Information


Jessica Barger
614-292-8858
OPT-CHAMPstudy@osu.edu

Back